Stay updated on Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial
Sign up to get notified when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.

Latest updates to the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page footer update shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a new revision of the page content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page footer revision label has been updated from **v3.5.2** to **v3.5.3**. This appears to be a general site release/version update rather than a change to the study details.SummaryDifference0.1%

- Check40 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page shows an added Revision: v3.5.0 and a removed Revision: v3.4.3. This appears to be an administrative versioning update rather than a modification to the study data or content.SummaryDifference0.1%

- Check76 days agoChange DetectedThe site revision was updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check98 days agoChange DetectedPrimary outcome maintenance phase wording updated to 'Baseline through Week 48' from 'post-randomization through Week 48'.SummaryDifference0.3%

Stay in the know with updates to Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.